Prospects and progress of immunotherapy for bladder cancer.UroTodayAreas covered: In this review, the authors provide an overview of the history and rationale for immunotherapy in bladder cancer. They also provide the currently available data evaluatin… Continue reading
Prospects and progress of immunotherapy for bladder cancer.UroTodayAreas covered: In this review, the authors provide an overview of the history and rationale for immunotherapy in bladder cancer. They also provide the currently available data evaluatin… Continue reading
Editas Medicine, Inc. (NASDAQ:EDIT) Sees Heavy Trading Volume with 1864K Shares Changing HandsHighlight PressCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (… Continue reading
Editas Medicine, Inc. (NASDAQ:EDIT) Experiences Heavier than Usual Trading VolumeFirst News 24CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotell… Continue reading
Editas Medicine, Inc. (NASDAQ:EDIT) Experiences Heavier than Usual Trading VolumeFirst News 24CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotell… Continue reading
Extensive analysis reveals immune system dynamics after stem cell transplantation in leukemia patientsNews-Medical.netBy combining new system-biological analyses and advanced data analysis, researchers at Karolinska Institutet have been able to monitor… Continue reading
TIME |
FDA Cracks Down on Stem Cell Clinics But Patients Are Still at Risk
TIME On Monday, the U.S. Food and Drug Administration (FDA) announced that the agency is targeting clinics that offer unproven stem cell therapies, calling such offices “unscrupulous clinics” selling “so-called cures.” The FDA seized materials from one … FDA cracks down on clinics selling unapproved stem cell therapiesCBS News Finally, FDA Is Cracking Down on Highly Dangerous ‘Treatments’ From Stem Cell ClinicsScienceAlert FDA moves to curb dangerous stem cell clinicsPhilly.com Los Angeles Times –New York Times –NPR –FDA.gov all 120 news articles » |